JPRN-UMIN000041321招募中4 期
emborexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study - Lemborexant for insomnia in patients with psychiatric disorder
Fujita Health University School of Medicine0 个研究点目标入组 100 人开始时间: 2020年8月5日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following exclusion criteria will be applied: taking any sleeping pills other than ramelteon, zolpidem, zopiclone, or eszopiclone at baseline; contraindication to suvorexant; patients with coma; addiction to psychostimulants or alcohol; pregnancy or breastfeeding; neurological or systemic diseases; and anyone considered inappropriate to participate by the attending physician. We will not include any patient who received benzodiazepines before the study because sleeping pills other than the Z drugs (zolpidem, zopiclone, or eszopiclone) or ramelteon.
研究者
相似试验
已完成
不适用
Suvorexant for the treatment of insomnia in patients with psychiatric disorderspsychiatric disordersJPRN-UMIN000024941Fujita Health University School of Medicine50
已完成
不适用
Efficacy and safety of lemborexant in insomnia patients with nocturia.JPRN-UMIN000044383Kyowakai Medical Corporation Kyoritsu Hospital30
招募中
1 期
Daridorexant to treat insomnia in patients with mild cognitive impairment and mild to moderate Alzheimer disease.Insomnia DisorderSLEEPAlzheimer DiseaseMedDRA version: 20.0Level: LLTClassification code: 10078083Term: Insomnia disorder Class: 10037175CTIS2023-503301-10-00niversity Hospital Of Montpellier62
尚未招募
Unknown
se of Lemborexant for Insomnia in Our Clinic: A Retrospective StudyInsomniaJPRN-UMIN000054075Wellness General Clinic1,000
已完成
Unknown
Effects of Lemborexant on insomnia in patients with schizophrenia : A randomized controlled studyInsomnia in patients with schizophreniaJPRN-UMIN000049310Department of Psychiatry, Kurita Hospital, 695 Kurita Nagano-City Nagano, Japan, 380-0921